Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Trastuzumab and Pyrotinib
Sponsor: Chinese Academy of Medical Sciences